{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:16:21Z","timestamp":1792088181376,"version":"4.4.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.lfs.2021.119329","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T16:29:32Z","timestamp":1615307372000},"page":"119329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Investigation into the role of anti-diabetic agents in cachexia associated with metastatic cancer"],"prefix":"10.1016","volume":"274","author":[{"given":"Vivek","family":"Bora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhoomika M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2021.119329_bb0005","series-title":"StatPearls [Internet]","article-title":"Cachexia. [updated 2019 Nov 11]","author":"Rogers","year":"2020"},{"key":"10.1016\/j.lfs.2021.119329_bb0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jcsm.12402","article-title":"Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review","volume":"10","author":"Anker","year":"2019","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.lfs.2021.119329_bb0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4081\/ejtm.2019.7960","article-title":"Therapeutic strategies against cancer cachexia","volume":"29","author":"Argiles","year":"2019","journal-title":"European Journal of Translational Myology"},{"key":"10.1016\/j.lfs.2021.119329_bb0020","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1042\/BCJ20170032","article-title":"Novel targeted therapies for cancer cachexia","volume":"474","author":"Argil\u00e9s","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.lfs.2021.119329_bb0025","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.lfs.2021.119329_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nature Reviews Disease Primers"},{"key":"10.1016\/j.lfs.2021.119329_bb0035","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1101\/gad.276733.115","article-title":"Mechanisms of metabolic dysfunction in cancer-associated cachexia","volume":"30","author":"Petruzzelli","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.lfs.2021.119329_bb0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/07315724.1992.10718249","article-title":"A review of cancer cachexia and abnormal glucose metabolism in humans with cancer","volume":"11","author":"Tayek","year":"1992","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.lfs.2021.119329_bb0045","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.3390\/ijms21072321","article-title":"Cancer Cachexia and related metabolic dysfunction","volume":"21","author":"Fonseca","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2021.119329_bb0050","first-page":"62","article-title":"Effects of tumor removal and body weight loss on insulin resistance in patients with cancer","volume":"116","author":"Yoshikawa","year":"1994","journal-title":"Surgery"},{"key":"10.1016\/j.lfs.2021.119329_bb0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2008.09.005","article-title":"Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond","volume":"121","author":"Ganapathy","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2021.119329_bb0060","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/02841860600791491","article-title":"Protein, glucose and lipid metabolism in the cancer cachexia: a preliminary report","volume":"46","author":"Dodesini","year":"2007","journal-title":"Acta Oncol."},{"key":"10.1016\/j.lfs.2021.119329_bb0065","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2337\/diacare.29.02.06.dc05-1558","article-title":"Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin","volume":"29","author":"Bowker","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2021.119329_bb0070","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/1753-0407.12435","article-title":"Cancer risk of sulfonylureas in patients with type 2 diabetes mellitus: a systematic review","volume":"9","author":"Chen","year":"2017","journal-title":"J Diabetes"},{"key":"10.1016\/j.lfs.2021.119329_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0122660","article-title":"Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: possible anti-cachectic effect","volume":"10","author":"Beluzi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.119329_bb0080","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.nut.2013.12.005","article-title":"Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia","volume":"30","author":"Trobec","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.lfs.2021.119329_bb0085","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1139\/apnm-2013-0369","article-title":"Cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment","volume":"39","author":"Chevalier","year":"2014","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"10.1016\/j.lfs.2021.119329_bb0090","first-page":"221","article-title":"Diabetes medications and cancer risk: review of the literature","volume":"5","author":"Nguyen","year":"2012","journal-title":"American Health and Drug Benefits"},{"key":"10.1016\/j.lfs.2021.119329_bb0095","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis","volume":"3","author":"DeCensi","year":"2010","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.lfs.2021.119329_bb0100","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx815","article-title":"Insulin resistance and body composition in cancer patients","volume":"29","author":"Dev","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lfs.2021.119329_bb0105","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2424-9","article-title":"Metformin treatment modulates the tumour-induced wasting effects in muscle protein metabolism minimising the cachexia in tumour-bearing rats","volume":"16","author":"Oliveira","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2021.119329_bb0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/bjc.2015.453","article-title":"Measuring the biological effect of presurgical metformin treatment in endometrial cancer","volume":"114","author":"Sivalingam","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2021.119329_bb0115","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2015\/16015.6979","article-title":"Evaluation of anti cancer effects of DPP-4 inhibitors in colon cancer-an invitro study","author":"Amritha","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.lfs.2021.119329_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2016.11.404","article-title":"MA04.10 lung cancer growth is suppressed by CD26\/DPP4-inhibition via enhanced NK cell and macrophage recruitment","volume":"12","author":"Jang","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lfs.2021.119329_bb0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13300-014-0053-3","article-title":"Carcinogenicity risk assessment supports the chronic safety of Dapagliflozin, an inhibitor of sodium\u2013glucose co-transporter 2, in the treatment of type 2 diabetes mellitus","volume":"5","author":"Reilly","year":"2014","journal-title":"Diabetes Therapy"},{"key":"10.1016\/j.lfs.2021.119329_bb0130","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1007\/s00125-017-4430-0","article-title":"Bladder cancer in the EMPA-REG OUTCOME trial","volume":"60","author":"Kohler","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.lfs.2021.119329_bb0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/2042018815578599","article-title":"Short commentary on empagliflozin and its potential clinical impact","volume":"6","author":"Hinnen","year":"2015","journal-title":"Therapeutic Advances in Endocrinology and Metabolism"},{"key":"10.1016\/j.lfs.2021.119329_bb0140","first-page":"52","article-title":"An in-vitro and in silico anticancer study of FDA approved antidiabetic drugs glimepiride and Empagliflozin","volume":"10","author":"Uzma","year":"2020","journal-title":"Int. J. Pharm. Bio Sci."},{"key":"10.1016\/j.lfs.2021.119329_bb0145","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4161\/cbt.12.8.16442","article-title":"Hydrodynamic cell delivery for simultaneous establishment of tumor growth in mouse lung, liver and kidney","volume":"12","author":"Li","year":"2011","journal-title":"Cancer Biology and Therapy"},{"key":"10.1016\/j.lfs.2021.119329_bb0150","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.119329_bb0155","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0003-9861(61)90291-0","article-title":"The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid","volume":"93","author":"Woessner","year":"1961","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.lfs.2021.119329_bb0160","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1590\/S0102-86502012001000003","article-title":"An experimental model for the study of collagen fibers in skeletal muscle","volume":"27","author":"Calvi","year":"2012","journal-title":"Acta Cirurgica Brasileira"},{"key":"10.1016\/j.lfs.2021.119329_bb0165","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.lfs.2016.11.033","article-title":"TNF-\u03b1 and cancer cachexia: molecular insights and clinical implications","volume":"170","author":"Patel","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2021.119329_bb0170","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7153610","article-title":"Modulating metabolism to improve cancer-induced muscle wasting","author":"Penna","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2021.119329_bb0175","first-page":"243","article-title":"Mechanisms for fiber-type specificity of skeletal muscle atrophy","volume":"16","author":"Wang","year":"2013","journal-title":"Current opinion in clinical nutrition and metabolic care"},{"key":"10.1016\/j.lfs.2021.119329_bb0180","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fonc.2020.00298","article-title":"Management of cancer cachexia: attempting to develop new pharmacological agents for new effective therapeutic options","volume":"10","author":"Marceca","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2021.119329_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173113","article-title":"Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model. Edited by Zane B Andrews","volume":"12","author":"Terawaki","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.119329_bb0190","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3748\/wjg.v19.i15.2298","article-title":"Dipeptidyl peptidase-4: a key player in chronic liver disease","volume":"19","author":"Itou","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2021.119329_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-016-0169-x","article-title":"Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes","volume":"8","author":"Jojima","year":"2016","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.lfs.2021.119329_bb0200","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/oby.2012.59","article-title":"Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats","volume":"20","author":"Devenny","year":"2012","journal-title":"Obesity"},{"key":"10.1016\/j.lfs.2021.119329_bb0205","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00380-008-1137-7","article-title":"Metformin inhibits nuclear factor \u03bab activation and decreases serum high-sensitivity C-reactive protein level in experimental atherogenesis of rabbits","volume":"24","author":"Li","year":"2009","journal-title":"Heart Vessel."},{"key":"10.1016\/j.lfs.2021.119329_bb0210","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.diabres.2010.11.030","article-title":"Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients","volume":"93","author":"Chakraborty","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.lfs.2021.119329_bb0215","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.semcdb.2019.05.010","article-title":"The multifaceted effects of metformin on tumor microenvironment","volume":"98","author":"Kurelac","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.lfs.2021.119329_bb0220","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.tips.2009.08.003","article-title":"Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?","volume":"30","author":"Yazbeck","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2021.119329_bb0225","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/jcsm.12202","article-title":"Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction","volume":"8","author":"Enoki","year":"2017","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.lfs.2021.119329_bb0230","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopha.2018.10.016","article-title":"Teneligliptin protects against hypoxia\/reoxygenation-induced endothelial cell injury","volume":"109","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2021.119329_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-016-0144-6","article-title":"Dipeptidyl peptidase-4 inhibitors improve arterial stiffness, blood pressure, lipid profile and inflammation parameters in patients with type 2 diabetes mellitus","volume":"8","author":"Duvnjak","year":"2016","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.lfs.2021.119329_bb0240","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.2337\/dc12-0199","article-title":"Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition","volume":"35","author":"Rizzo","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2021.119329_bb0245","doi-asserted-by":"crossref","first-page":"118","DOI":"10.14310\/horm.2002.1512","article-title":"Effect of vildagliptin on hsCRP and arterial stiffness in patients with type 2 diabetes mellitus","volume":"14","author":"Zografou","year":"2015","journal-title":"Hormones"},{"key":"10.1016\/j.lfs.2021.119329_bb0250","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1371\/journal.pone.0054442","article-title":"Effects of SGLT2 inhibition in human kidney proximal tubular cells-renoprotection in diabetic nephropathy?","volume":"8","author":"Panchapakesan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.119329_bb0255","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ebiom.2017.05.028","article-title":"SGLT2 inhibition by Empagliflozin promotes fat utilization and Browning and Attenuates inflammation and insulin resistance by polarizing M2 macrophages in diet-induced obese mice","volume":"20","author":"Xu","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.lfs.2021.119329_bb0260","series-title":"Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Increases Circulating Zinc- \u0391 2 -Glycoprotein Levels in Patients with Type 2 Diabetes","first-page":"1","author":"Liao","year":"2016"},{"key":"10.1016\/j.lfs.2021.119329_bb0265","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10863-007-9086-x","article-title":"The Warburg effect and its cancer therapeutic implications","volume":"39","author":"Chen","year":"2007","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.lfs.2021.119329_bb0270","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3390\/ijms18102145","article-title":"A functional interplay between IGF-1 and adiponectin","volume":"18","author":"Orr\u00f9","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2021.119329_bb0275","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1172\/jci.insight.93936","article-title":"Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes","volume":"3","author":"Bahne","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.lfs.2021.119329_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2015.00386","article-title":"DPP4 in diabetes","volume":"6","author":"R\u00f6hrborn","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2021.119329_bb0285","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4172\/2155-9880.1000494","article-title":"In vitro study examining the activity of Vildagliptin and Sitagliptin against hyperglycemia-induced effects in human umbilical vein endothelial cells","volume":"08","author":"Sala","year":"2017","journal-title":"Journal of Clinical & Experimental Cardiology"},{"key":"10.1016\/j.lfs.2021.119329_bb0290","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.biopha.2018.12.036","article-title":"Dipeptidyl peptidase-4 inhibition protects the liver of insulin-resistant female rats against triglyceride accumulation by suppressing uric acid","volume":"110","author":"Omolekulo","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2021.119329_bb0295","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12020-016-1052-0","article-title":"The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory","volume":"56","author":"Pujadas","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.lfs.2021.119329_bb0300","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI72227","article-title":"Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients","volume":"124","author":"Ferrannini","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.lfs.2021.119329_bb0305","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI70704","article-title":"Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production","volume":"124","author":"Merovci","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.lfs.2021.119329_bb0310","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1511698112","article-title":"Functional expression of sodium-glucose transporters in cancer","volume":"112","author":"Scafoglio","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.119329_bb0315","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.dsx.2020.04.024","article-title":"Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis","volume":"14","author":"Cure","year":"2020","journal-title":"Diabetes and Metabolic Syndrome: Clinical Research and Reviews"},{"key":"10.1016\/j.lfs.2021.119329_bb0320","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2021.119329_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082225","article-title":"mTOR and tumor Cachexia","volume":"19","author":"Duval","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2021.119329_bb0330","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1158\/0008-5472.CAN-14-0057","article-title":"Myostatin gene inactivation prevents skeletal muscle wasting in cancer","volume":"74","author":"Gallot","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2021.119329_bb0335","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1210\/jc.2008-1400","article-title":"Dipeptidyl-peptidase-IV inhibition augments postprandial lipid mobilization and oxidation in type 2 diabetic patients","volume":"94","author":"Boschmann","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2021.119329_bb0340","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1172\/JCI0217303","article-title":"Fatty acid oxidation in human skeletal muscle","volume":"110","author":"Jensen","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.lfs.2021.119329_bb0345","first-page":"191","article-title":"Lipid metabolism in Cachexia","author":"Manzato","year":"2007","journal-title":"Cachexia and Wasting: A Modern Approach"},{"key":"10.1016\/j.lfs.2021.119329_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00033","article-title":"Fat wasting is damaging: role of adipose tissue in cancer-associated Cachexia","volume":"8","author":"Sun","year":"2020","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10.1016\/j.lfs.2021.119329_bb0355","first-page":"174","article-title":"The effect of administration of metformin on lipid profile changes and insulin resistance in patients with polycystic ovary syndrome","volume":"12","author":"Karimzadeh","year":"2007","journal-title":"Middle East Fertility Society Journal"},{"key":"10.1016\/j.lfs.2021.119329_bb0360","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.molmet.2019.08.011","article-title":"Metformin prevents the pathological browning of subcutaneous white adipose tissue","volume":"29","author":"Auger","year":"2019","journal-title":"Molecular Metabolism"},{"key":"10.1016\/j.lfs.2021.119329_bb0365","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/abbs\/gmx106","article-title":"Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells","volume":"50","author":"Saini","year":"2018","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.lfs.2021.119329_bb0370","doi-asserted-by":"crossref","first-page":"57733","DOI":"10.18632\/oncotarget.17496","article-title":"Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials","volume":"8","author":"Troncone","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2021.119329_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207947","article-title":"Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elderly \u2013 a meta-analysis. Edited by Clemens F\u00fcrnsinn","volume":"13","author":"Solym\u00e1r","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.119329_bb0380","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejphar.2012.09.024","article-title":"A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations","volume":"696","author":"Fukuda-Tsuru","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2021.119329_bb0385","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejphar.2013.11.030","article-title":"The novel dipeptidyl peptidase-4 inhibitor teneligliptin prevents high-fat diet-induced obesity accompanied with increased energy expenditure in mice","volume":"723","author":"Fukuda-Tsuru","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2021.119329_bb0390","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3389\/fendo.2019.00780","article-title":"Insights into GLP-1 and GIP actions emerging from Vildagliptin mechanism studies in man","volume":"10","author":"Foley","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.lfs.2021.119329_bb0395","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2147\/VHRM.S10952","article-title":"Weight neutrality with the DPP-4 inhibitor, vildagliptin: mechanistic basis and clinical experience","volume":"6","author":"Foley","year":"2010","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.lfs.2021.119329_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-017-0443-4","article-title":"A comparison of effects of DPP-4 inhibitor and SGLT2 inhibitor on lipid profile in patients with type 2 diabetes","volume":"16","author":"Cha","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.lfs.2021.119329_bb0405","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6305735","article-title":"The SGLT-2 inhibitor Dapagliflozin has a therapeutic effect on atherosclerosis in diabetic ApoE\u2212\/\u2212mice","volume":"2016","author":"Leng","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.lfs.2021.119329_bb0410","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1200\/JCO.2009.19.6410","article-title":"Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer","volume":"27","author":"Jiralerspong","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2021.119329_bb0415","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3816\/CBC.2008.n.060","article-title":"Insulin-lowering effects of metformin in women with early breast cancer","volume":"8","author":"Goodwin","year":"2008","journal-title":"Clinical Breast Cancer"},{"key":"10.1016\/j.lfs.2021.119329_bb0420","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1464-410X.2011.10555.x","article-title":"A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy","volume":"109","author":"Nobes","year":"2012","journal-title":"BJU Int."},{"key":"10.1016\/j.lfs.2021.119329_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118870","article-title":"Vildagliptin, a dipeptidyl peptidase-4 inhibitor, reduces betel-nut induced carcinogenesis in female mice","volume":"266","author":"Nath","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2021.119329_bb0430","article-title":"Evaluation of cooperative anti-leukemic effects of nilotinib and vildagliptin in Ph + chronic myeloid leukemia","author":"Willmann","year":"2017","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.lfs.2021.119329_bb0435","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/ndt\/gfy397","article-title":"Dipeptidyl peptidase-4 inhibitor teneligliptin accelerates recovery from cisplatin-induced acute kidney injury by attenuating inflammation and promoting tubular regeneration","volume":"34","author":"Iwakura","year":"2019","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1016\/j.lfs.2021.119329_bb0440","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1021\/acsptsci.0c00144","article-title":"Empagliflozin and doxorubicin synergistically inhibit the survival of triple-negative breast cancer cells via interfering with the mTOR pathway and inhibition of calmodulin: in vitro and molecular docking studies","volume":"3","author":"Eliaa","year":"2020","journal-title":"ACS Pharmacology and Translational Science"},{"key":"10.1016\/j.lfs.2021.119329_bb0445","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3390\/molecules25030495","article-title":"Dapagliflozin inhibits cell adhesion to collagen I and IV and increases ectodomain proteolytic cleavage of DDR1 by increasing ADAM10 activity","volume":"25","author":"Okada","year":"2020","journal-title":"Molecules"}],"updated-by":[{"DOI":"10.1016\/j.lfs.2023.121905","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000}}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521003143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521003143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:49:07Z","timestamp":1758401347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521003143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":89,"alternative-id":["S0024320521003143"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119329","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation into the role of anti-diabetic agents in cachexia associated with metastatic cancer","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119329"}}